User profiles for Shudong Xiao
Shudong XiaoUniversity of Notre Dame Verified email at nd.edu Cited by 5143 |
Intrinsic and extrinsic performance limits of graphene devices on SiO2
The linear dispersion relation in graphene 1 , 2 gives rise to a surprising prediction: the
resistivity due to isotropic scatterers, such as white-noise disorder 3 or phonons 4 , 5 , 6 , 7 , 8 , is …
resistivity due to isotropic scatterers, such as white-noise disorder 3 or phonons 4 , 5 , 6 , 7 , 8 , is …
[HTML][HTML] miR-21 plays a pivotal role in gastric cancer pathogenesis and progression
…, Z Li, C Gao, P Chen, J Chen, W Liu, S Xiao… - Laboratory …, 2008 - Elsevier
Gastric cancer causes nearly one million deaths worldwide per year. Although Helicobacter
pylori infection is the main risk factor, in about 80% or more of gastric cancers, the molecular …
pylori infection is the main risk factor, in about 80% or more of gastric cancers, the molecular …
Esaki diodes in van der Waals heterojunctions with broken-gap energy band alignment
van der Waals (vdW) heterojunctions composed of two-dimensional (2D) layered materials
are emerging as a solid-state materials family that exhibits novel physics phenomena that …
are emerging as a solid-state materials family that exhibits novel physics phenomena that …
High Efficacy of 14‐Day Triple Therapy‐Based, Bismuth‐Containing Quadruple Therapy for Initial Helicobacter pylori Eradication
Q Sun, X Liang, Q Zheng, W Liu, S Xiao, W Gu… - Helicobacter, 2010 - Wiley Online Library
Background: The success rate of currently recommended 7‐day triple therapy with a PPI plus
amoxicillin and clarithromycin has fallen into the unacceptable range. It is urgent to look for …
amoxicillin and clarithromycin has fallen into the unacceptable range. It is urgent to look for …
Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective …
…, X Xu, Q Zheng, W Zhang, Q Sun, W Liu, S Xiao… - Clinical …, 2013 - Elsevier
BACKGROUND & AIMS: We assessed the efficacy and safety of 4 bismuth-containing quadruple
regimens as empiric therapies for Helicobacter pylori infections in patients who did not …
regimens as empiric therapies for Helicobacter pylori infections in patients who did not …
Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy
W Zhang, Q Chen, X Liang, W Liu, S Xiao, DY Graham… - Gut, 2015 - gut.bmj.com
Objective To evaluate the efficacy and tolerability of replacing tetracycline with amoxicillin in
bismuth quadruple therapy. Design Subjects who were infected with Helicobacter pylori and …
bismuth quadruple therapy. Design Subjects who were infected with Helicobacter pylori and …
Reduced microRNA‐218 expression is associated with high nuclear factor kappa B activation in gastric cancer
C Gao, Z Zhang, W Liu, S Xiao, W Gu… - … International Journal of …, 2010 - Wiley Online Library
BACKGROUND: Poor expression of microRNAs (miRs) reportedly plays an important role in
gastric carcinogenesis. Large‐scale microarray assays have indicated that there is …
gastric carcinogenesis. Large‐scale microarray assays have indicated that there is …
Effect of fluoroquinolone resistance on 14‐day levofloxacin triple and triple plus bismuth quadruple therapy
…, X Liang, W Zhang, Q Sun, W Liu, S Xiao… - …, 2013 - Wiley Online Library
Objective Levofloxacin has been proposed to replace clarithromycin for Helicobacter pylori
treatment. Seven‐ and 10‐day fluoroquinolone triple therapies have generally failed to …
treatment. Seven‐ and 10‐day fluoroquinolone triple therapies have generally failed to …
Charged impurity scattering in bilayer graphene
We have examined the impact of charged impurity scattering on charge carrier transport in
bilayer graphene (BLG) by deposition of potassium in ultrahigh vacuum at low temperature. …
bilayer graphene (BLG) by deposition of potassium in ultrahigh vacuum at low temperature. …
Rescue therapy for Helicobacter pylori eradication: a randomized non-inferiority trial of amoxicillin or tetracycline in bismuth quadruple therapy
…, W Zhang, Q Fu, X Liang, W Liu, S Xiao… - Official journal of the …, 2016 - journals.lww.com
Objectives: To compare the efficacy and safety of bismuth-containing quadruple therapy with
tetracycline or amoxicillin for rescue treatment ofHelicobacter pylori. Methods: The study …
tetracycline or amoxicillin for rescue treatment ofHelicobacter pylori. Methods: The study …